New Markets Tax Credit Coalition

MedRhythms, Inc.

Investment

  • NMTC Amount: $3,974,956
  • Total Project Cost: $24,974,956

IMPACT

  • 18 FTE jobs
  • Jobs must exceed 1.2X the living wage in the region and offer quality benefits, which include, but not limited to medical insurance, paid time off, and wealth creation options.

Investor

Project Description

MedRhythms is the developer of a digital therapeutics platform to deliver rhythmic auditory stimulation therapy to chronic stroke survivors. While RAS therapy typically takes place in a clinical setting, MedRhythms’s product will provide the same experience in the patient’s home. This project provided the Company with working capital to continue MedRhythm’s growth in Maine.

MAP

Address: 183 Middle Street, Suite 300, Portland, ME 4101

Census Tract: 23005000300

Other Maine Projects

Financed hip, modern offices of Vets First Choice on Commercial Street in Portland. The company provides pharmacy services for animal care at its 170,000 sq. ft. headquarters.

The purchase and installment of medical manufacturing equipment at US processing facility of Mölnlycke, a Swedish-owned wound-care manufacturing, eliminating need to ship product overseas for conversion.
The tissue production facility has created 80 direct, full-time jobs, while preserving the 320 jobs at the Woodland Pulp facility.

NMTC financing totaling $2,000,000 to was used to improve a 13,087 sq. ft. commercial building located at 80 Exchange Street in Portland, ME. Tenants consist of various restaurants, retail and